Cardio Diagnostics Holdings, Inc.

CDIO · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
69
SEC Filings

Business Summary

Cardio Diagnostics Holdings, Inc. is a molecular diagnostics company focused on cardiovascular disease (CVD) detection using epigenetic and AI-driven technologies. The company offers Epi+Gen CHD and PrecisionCHD, commercially available blood-based tests that leverage DNA methylation biomarkers to assess coronary heart disease risk. Its technology is built on a licensed platform from the University of Iowa Research Foundation and targets patients, healthcare professionals, and other key clinical channels.

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCDIOdiscussed_in_filing Artificial Intelligence
topic_mentionCDIOdiscussed_in_filing Healthcare & Bio
topic_mentionCDIOdiscussed_in_filing Platform & Ecosystem
topic_mentionCDIOdiscussed_in_filing Artificial Intelligence
topic_mentionCDIOdiscussed_in_filing Healthcare & Bio
topic_mentionCDIOdiscussed_in_filing Platform & Ecosystem
topic_mentionCDIOdiscussed_in_filing Artificial Intelligence
topic_mentionCDIOdiscussed_in_filing Healthcare & Bio
topic_mentionCDIOdiscussed_in_filing Platform & Ecosystem
topic_mentionCDIOdiscussed_in_filing Artificial Intelligence
topic_mentionCDIOdiscussed_in_filing Healthcare & Bio
topic_mentionCDIOdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001553350-26-000023EDGAR87K words
2025-03-202024-12-310001079973-25-000428EDGAR—
2024-04-012023-12-310001079973-24-000480EDGAR—
2023-03-312022-12-310001079973-23-000412EDGAR—
2022-03-312021-12-310001079973-22-000372EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001079973-25-001686EDGAR25K words
2025-08-142025-06-300001079973-25-001287EDGAR—
2025-05-152025-03-310001553350-25-000044EDGAR—
2024-11-132024-09-300001079973-24-001510EDGAR—
2024-08-122024-06-300001079973-24-001206EDGAR—
2024-05-152024-03-310001079973-24-000739EDGAR—
2023-11-132023-09-300001079973-23-001555EDGAR—
2023-08-142023-06-300001079973-23-001160EDGAR—
2023-05-152023-03-310001079973-23-000711EDGAR—
2022-11-072022-09-300001079973-22-001398EDGAR—
2022-08-102022-06-300001079973-22-000958EDGAR—
2022-05-122022-03-310001079973-22-000575EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-190001079973-26-000239EDGAR3K words
2025-10-150001079973-25-001612EDGAR—
2025-05-280001079973-25-000937EDGAR—
2025-05-130001079973-25-000781EDGAR—
2025-02-210001079973-25-000308EDGAR—
2024-12-040001079973-24-001660EDGAR—
2024-11-180001079973-24-001569EDGAR—
2024-06-070001079973-24-000850EDGAR—
2024-04-020001079973-24-000500EDGAR—
2024-02-020001079973-24-000172EDGAR—

69 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE ICCC — IMMUCELL CORP /DE/

Tags

cardiovascular-disease-diagnostics epigenetic-testing molecular-diagnostics clinical-laboratory-services dna-methylation-biomarkers epigenetic-testing laboratory-developed-tests-(ldts)

Company Identity

CIK0001870144
TickerCDIO
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c2dd2a93d2c86ba39458931fb7aa9d61b168134de6935bd822c8227793698218
parent: 7253ee828264710a191944818263b9530cafcd1732bbe19f5e0609c33f56e9f1
content hash: 9e8493c5df95e88ed9cefbfed24aa6ea7c4b29bad23b9b9d36bea42ff751400c
signed: 2026-04-13T04:44:15.214Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf